Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,215 AUD | -6,52% |
|
-14,00% | -10,42% |
11/06 | Artrya tekent vijfjarige overeenkomst met Cone Health in VS; aandelen dalen 4% | MT |
07/06 | Artrya dient tweede Q-Submission in om FDA-aanvraag af te ronden | MT |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mathew Regan
CEO | Chief Executive Officer | - | 27-03-23 |
Mark Wainwright
DFI | Director of Finance/CFO | - | 01-09-21 |
Jacob Agris
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-22 |
Girish Dwivedi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julien Flack
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-19 |
Jim Bonnette
PRN | Corporate Officer/Principal | - | 01-01-22 |
Riaz Kingston
PRN | Corporate Officer/Principal | - | 01-07-22 |
Kevin Hart
SEC | Corporate Secretary | 62 | 07-10-22 |
Janice Marcon
HRO | Human Resources Officer | - | 01-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jacque Sokolov
BRD | Director/Board Member | 69 | 01-08-22 |
Chairman | 70 | 01-02-21 | |
Catherine Hill
BRD | Director/Board Member | 65 | 22-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 78 648 993 | 43 484 598 ( 55,29 %) | 0 | 55,29 % |
Bedrijfsgegevens
![Adres Artrya Limited(AYA)](https://cdn.zonebourse.com/static/address/128506340.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,42% | 12,05 mln. | |
-15,37% | 8,55 mld. | |
+68,94% | 4,23 mld. | |
+3,72% | 2,68 mld. | |
+0,35% | 2,61 mld. | |
-55,09% | 1,82 mld. | |
-18,60% | 1,66 mld. | |
-21,23% | 1,42 mld. | |
+15,60% | 1,19 mld. | |
-49,14% | 1,05 mld. |